TipRanks
Go Ultimate55% OFF

AstraZeneca (AZN) Income Statement

AstraZeneca Income Statement

Last quarter (Q3 2026), AstraZeneca's total revenue was $16.34B, an increase of 7.56% from the same quarter last year. In Q3, AstraZeneca's net income was $3.14B. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 58.74B$ 52.94B$ 46.58B$ 44.25B$ 37.11B
$ 48.11B$ 39.70B$ 34.45B$ 28.04B$ 22.60B
$ 34.36B$ 27.18B$ 24.88B$ 22.99B$ 19.79B
Depreciation and Amortization$ 5.73B$ 5.07B$ 5.39B$ 5.25B$ 4.10B
$ 19.83B$ 14.96B$ 13.57B$ 8.64B$ 4.66B
$ 13.74B$ 12.52B$ 9.57B$ 5.05B$ 2.81B
$ -1.34B$ -4.01B$ -2.55B$ -2.55B$ -3.07B
$ 12.40B$ 8.51B$ 7.02B$ 2.50B$ -259.92M
$ 10.22B$ 6.89B$ 6.06B$ 3.28B$ 109.85M
Per Share Metrics
Basic EPS$ 6.60$ 4.44$ 3.91$ 2.12$ 0.08
Diluted EPS$ 6.54$ 4.41$ 3.88$ 2.10$ 0.08
Weighted Average Shares Outstanding1.55B1.55B1.56B1.55B1.42B
Weighted Average Shares Outstanding (Diluted)1.56B1.56B1.56B1.56B1.43B

Currency in USD

AstraZeneca Earnings and Revenue History

025B50B75B0 %8 %16 %24 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin